What is he best known for?
The fields of study he is best known for:
Yunhui Liu focuses on Gene knockdown, Glioma, Cancer research, microRNA and Stem cell.
His studies deal with areas such as Gene silencing, PI3K/AKT/mTOR pathway and Cell biology as well as Gene knockdown.
His Glioma research incorporates elements of Carcinogenesis, Cell growth and Long non-coding RNA.
His Cell growth study combines topics from a wide range of disciplines, such as Cell and Downregulation and upregulation.
The Cancer research study combines topics in areas such as Apoptosis and Regulation of gene expression, Gene Knockdown Techniques.
His studies in microRNA integrate themes in fields like Cell culture, Transfection, Transcription factor, Molecular biology and RNA interference.
His most cited work include:
- Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152 (221 citations)
- Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21☆ (140 citations)
- Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a (126 citations)
What are the main themes of his work throughout his whole career to date?
Yunhui Liu mainly focuses on Cancer research, Glioma, Cell biology, Gene knockdown and microRNA.
His study in Cancer research is interdisciplinary in nature, drawing from both Autophagy, Cell growth, Carcinogenesis, Immunology and Stem cell.
His study explores the link between Glioma and topics such as Immunohistochemistry that cross with problems in Survival analysis.
While the research belongs to areas of Cell biology, Yunhui Liu spends his time largely on the problem of Molecular biology, intersecting his research to questions surrounding Downregulation and upregulation, Western blot, Vascular permeability, Gene silencing and Small hairpin RNA.
Yunhui Liu focuses mostly in the field of Gene knockdown, narrowing it down to matters related to PI3K/AKT/mTOR pathway and, in some cases, Viability assay.
His microRNA research includes themes of Regulation of gene expression and RNA interference.
He most often published in these fields:
- Cancer research (44.83%)
- Glioma (44.83%)
- Cell biology (39.08%)
What were the highlights of his more recent work (between 2016-2020)?
- Cancer research (44.83%)
- Glioma (44.83%)
- Gene knockdown (31.03%)
In recent papers he was focusing on the following fields of study:
Yunhui Liu mainly investigates Cancer research, Glioma, Gene knockdown, Cell biology and Angiogenesis.
His research integrates issues of Autophagy, Apoptosis, Cell growth, RNA and Stem cell in his study of Cancer research.
His research investigates the connection with Cell growth and areas like microRNA which intersect with concerns in CDC25A.
His study connects Matrix metalloproteinase and Glioma.
His studies deal with areas such as PI3K/AKT/mTOR pathway and Downregulation and upregulation, Long non-coding RNA as well as Gene knockdown.
His Cell biology research includes themes of Molecular biology and Gene silencing.
Between 2016 and 2020, his most popular works were:
- TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway. (125 citations)
- Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122. (75 citations)
- Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway (69 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Glioma, Cancer research, Gene knockdown, microRNA and Cell growth.
His study in Glioma is interdisciplinary in nature, drawing from both Reporter gene, Stem cell, Messenger RNA and GAS5.
His Gene knockdown study deals with the bigger picture of Apoptosis.
His microRNA study combines topics in areas such as Endothelial stem cell, Vascular endothelial cell proliferation, Cell, Cell culture and Autophagy.
The concepts of his Cell growth study are interwoven with issues in Downregulation and upregulation and Flow cytometry.
His Protein kinase B research incorporates elements of Tube formation and Angiogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
